Wednesday, February 17, 2016 by Tara Paras
The rate of Alzheimer’s disease, the third-leading cause of death behind heart disease and cancer, has risen almost exponentially over the past few decades, and the numbers are expected to triple by 2050.
Despite these rising numbers, Big Pharma has thankfully been clueless so far, as more effective, less expensive and less toxic remedies are made available to the public.
Coconut oil’s medium-chain triglycerides (MCTs), Chinese medicinal herbs and Ayurveda are just some of the known remedies naturally helping those suffering from Alzheimer’s.
Now, another effective, non-pharmaceutical solution has been discovered — cannabis.
Late-stage Alzheimer’s victims are said to be comparable to children suffering from autism. In the following anecdotal case reported by Natural News, a daughter tells the story of how cannabis helped improve her mother’s condition:
“A daughter tells the arduous caretaker story of managing her mother’s final stages of Alzheimer’s by getting her on medical marijuana and off pharmaceuticals. Her mother arrived at her Oregon home in really bad shape with Alzheimer’s with a prognosis of six months to live.
“This older lady was not the type who took advantage of holistic medicine and organic foods and supplements. In addition to her Alzheimer’s, she was on several other medications for other ailments. But the crafty inclusion of some home-cooked organic meals and cannabis while taking care of her produced very positive results.
“Her cognitive abilities improved considerably, and she became much more sociable and cooperative instead of feisty, angry, inappropriate and antisocial, which are all symptoms of Alzheimer’s, in addition to the gross absence of memory.
“Her mother did pass away peacefully and lovingly at age 83 after the mother-daughter bond was firmly re-established. In other words, she exited the earthly realm in a much better state than if she had not been exposed to cannabis treatments.”
According to a 2013 Spanish study titled “CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in A[beta]PP/PS1 mice,” “stimulation of CB2 [cannabinoid] receptors ameliorates several altered parameters in Alzheimer’s disease such as impaired memory and learning, neuroinflammation, oxidative stress damage and oxidative stress responses, selected tau kinases, and tau hyperphosphorylation around plaques.”
In addition to this, scientists at Sarasota, Florida’s independent Roskamp Institute have also come up with a study detailing the mechanics of Alzheimer’s and how cannabis demonstrates efficacy without negative side effects.
Gary Wenk, Ph.D., professor of neuroscience, immunology and medical genetics at Ohio State University, told TIME, “I’ve been trying to find a drug that will reduce brain inflammation and restore cognitive function in rats for over 25 years; cannabinoids are the first and only class of drugs that have ever been effective.”
Wenk added, “I think that the perception about this drug is changing and in the future people will be less fearful.”
Let’s wait and (hopefully) see.